Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,893 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Carotenoid intake and esophageal cancer risk: a meta-analysis.
Ge XX, Xing MY, Yu LF, Shen P. Ge XX, et al. Among authors: shen p. Asian Pac J Cancer Prev. 2013;14(3):1911-8. doi: 10.7314/apjcp.2013.14.3.1911. Asian Pac J Cancer Prev. 2013. PMID: 23679292
[Advances on correlation of PET-CT findings with breast cancer molecular subtypes, treatment response and prognosis].
Pan J, He M, Ke W, Hu M, Wang M, Shen P. Pan J, et al. Among authors: shen p. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017 May 25;46(5):473-480. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017. PMID: 29488712 Chinese.
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
Xie J, Cao J, Wang JF, Zhang BH, Zeng XH, Zheng H, Zhang Y, Cai L, Wu YD, Yao Q, Zhao XC, Mao WD, Jiang AM, Chen SS, Yang SE, Wang SS, Wang JH, Pan YY, Ren BY, Chen YJ, Ouyang LZ, Lei KJ, Gao JH, Huang WH, Huang Z, Shou T, He YL, Cheng J, Sun Y, Li WM, Cui SD, Wang X, Rao ZG, Ma H, Liu W, Wu XY, Shen WX, Cao FL, Xiao ZM, Wu B, Tian SY, Meng D, Shen P, Wang BY, Wang Z, Zhang J, Wang L, Hu XC. Xie J, et al. Among authors: shen wx, shen p. Breast Cancer Res Treat. 2018 Apr;168(2):389-399. doi: 10.1007/s10549-017-4609-6. Epub 2017 Dec 11. Breast Cancer Res Treat. 2018. PMID: 29230663 Clinical Trial.
Interestingly, a substantial difference was noted during cycle 2, and the difference became bigger over cycles 3-4, reaching a statistical significance at cycle 4 in either incidence (P = 0.0309) or duration (P = 0.0289) favoring PEG-rhG-CSF. ...The corresponding in …
Interestingly, a substantial difference was noted during cycle 2, and the difference became bigger over cycles 3-4, reaching a statistical s …
[Analysis of serum metabonome of patients with breast cancer by gas chromatography-mass spectrometry].
Wang J, Yu LF, Shen P, Wang SF. Wang J, et al. Among authors: shen p. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Sep;38(5):478-84. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19830860 Chinese.
Herpes simplex virus type 2 or human herpesvirus 8 infection and prostate cancer risk: A meta-analysis.
Ge X, Wang X, Shen P. Ge X, et al. Among authors: shen p. Biomed Rep. 2013 May;1(3):433-439. doi: 10.3892/br.2013.82. Epub 2013 Mar 19. Biomed Rep. 2013. PMID: 24648964 Free PMC article.
Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a meta-analysis.
Ji LD, Zhang LN, Shen P, Wang P, Zhang YM, Xing WH, Xu J. Ji LD, et al. Among authors: shen p. J Hypertens. 2010 Mar;28(3):419-28. doi: 10.1097/HJH.0b013e32833456b9. J Hypertens. 2010. PMID: 20087216
RESULTS: Statistically significant associations with essential hypertension were identified for TT genotype of AGT M235T polymorphism (odds ratio 1.54, 95% confidence interval 1.16-2.03, P = 0.002) and DD genotype of ACE I/D polymorphism (odds ratio 1.61, 95% confidence in …
RESULTS: Statistically significant associations with essential hypertension were identified for TT genotype of AGT M235T polymorphism (odds …
Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer.
Zhang CX, Huang S, Xu N, Fang JW, Shen P, Bao YH, Mou BH, Shi MG, Zhong XL, Xiong PJ. Zhang CX, et al. Among authors: shen p. Anticancer Drugs. 2007 Jun;18(5):581-6. doi: 10.1097/CAD.0b013e3280146296. Anticancer Drugs. 2007. PMID: 17414627 Clinical Trial.
Efficacy and Cardiotoxicity of Liposomal Doxorubicin-Based Chemotherapy in Advanced Breast Cancer: A Meta-Analysis of Ten Randomized Controlled Trials.
Xing M, Yan F, Yu S, Shen P. Xing M, et al. Among authors: shen p. PLoS One. 2015 Jul 23;10(7):e0133569. doi: 10.1371/journal.pone.0133569. eCollection 2015. PLoS One. 2015. PMID: 26204517 Free PMC article. Review.
Liposomal doxorubicin-based chemotherapy was associated with a significant reduction in the risk of cardiotoxicity (OR = 0.46, 95% CI 0.23 to 0.92, p = 0.03) and a significant improvement in the overall response rate (ORR) (OR = 1.25, 95% CI 1.02 to 1.52, p=0.03) co …
Liposomal doxorubicin-based chemotherapy was associated with a significant reduction in the risk of cardiotoxicity (OR = 0.46, 95% CI 0.23 t …
Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer.
Chen J, Hong D, Zhai Y, Shen P. Chen J, et al. Among authors: shen p. World J Surg Oncol. 2015 Mar 26;13:122. doi: 10.1186/s12957-015-0530-9. World J Surg Oncol. 2015. PMID: 25889889 Free PMC article.

RESULTS: Our analysis indicated that elevated pre-treatment NLR predicted poorer OS (HR: 2.16, 95% CI: 1.86 to 2.51, P < 0.001) and PFS (HR 2.78, 95% CI: 1.95 to 3.96; P < 0.00001) in patients with GC. Over a 3-year follow-up period, high NLR was a significant

RESULTS: Our analysis indicated that elevated pre-treatment NLR predicted poorer OS (HR: 2.16, 95% CI: 1.86 to 2.51, P < 0.001) an

Efficacy and safety profile of celecoxib for treating advanced cancers: a meta-analysis of 11 randomized clinical trials.
Chen J, Shen P, Zhang XC, Zhao MD, Zhang XG, Yang L. Chen J, et al. Among authors: shen p. Clin Ther. 2014 Aug 1;36(8):1253-63. doi: 10.1016/j.clinthera.2014.06.015. Epub 2014 Jul 10. Clin Ther. 2014. PMID: 25016505 Review.
Subgroup analysis found that the ORR results were significant with non-small cell lung cancer (RR = 1.29; 95% CI, 1.08-1.54; P = 0.005), colorectal cancer (RR = 1.32; 95% CI, 1.02-1.72; P = 0.037), chemotherapy treatment (RR = 1.22; 95% CI, 1.07-1.39; P = 0.0 …
Subgroup analysis found that the ORR results were significant with non-small cell lung cancer (RR = 1.29; 95% CI, 1.08-1.54; P = 0.00 …
1,893 results
Jump to page
Feedback